Twist Bioscience
TWST
Operating Margin for Twist Bioscience (TWST)
Operating Margin as of May 2024 (TTM): -92.90%
According to Twist Bioscience 's latest financial reports and stock price the company's current Operating Margin is -92.90%. At the end of 2022 the company had an Operating Margin of -112.14%.
Operating Margin history for Twist Bioscience from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -112.14% | -3.66% |
| 2021 | -116.39% | -24.85% |
| 2020 | -154.88% | -21.55% |
| 2019 | -197.44% | -29.29% |
| 2018 | -279.21% | -49.07% |
| 2017 | -548.25% | -71.78% |
| 2016 | -1,943.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 536.73% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 38.86% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 61.00% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -59.61% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.